Oral Candida spp carriers: its prevalence in patients with type 2 Diabetes Mellitus^*

Portadores de Candida spp na cavidade oral: a sua prevalência em pacientes com diabetes mellitus tipo 2

Abstracts

BACKGROUND:

Prevalence of oral candidiasis in diabetic patients is 13.7-64%. Candida albicans was the most frequently isolated species (75-86.5%).

OBJECTIVE:

To obtain the prevalence of Candida carriers among patients with type 2 diabetes mellitus to identify the species of the yeast. Study design: It is an open, observational, descriptive, cross-sectional, and prospective study.

METHODS:

We included voluntary patients from the National Diabetes Marathon and performed a blood glucose measurement, sialometry test, Gram-stained exfoliative cytology, and culture on Sabouraud dextrose agar and CHROMagar Candida TM. Results were analyzed using descriptive statistics.

RESULTS:

We examined 141 patients (mean age 57 years): 103 women (73%) and 38 men (26.9%). Exfoliative cytology was positive in 32 cases (23 with oral lesions); 78 had oral lesions but no Candida (93.9%). Candida was isolated in 58 patients (41.1%), 21 (45.6 %) had blood glucose greater than 126 mg/dl, and 37 (38.9%) had less than 126 mg/dl. The most frequent species was C. albicans (82.7%). Forty-two Candida carriers had salivary flow greater than 20 mm (72.4%), and 16 (27.5%) had hyposalivation. Candida was isolated in 25 of 79 patients with dental prosthesis (31.6%), 9 of 15 were smokers (60%), and 22 of 71 had symptoms (30.9%).

CONCLUSIONS:

Prevalence of oral Candida carriers in patients with type 2 diabetes mellitus in Mexico was similar to that found in other countries; exfoliative cytology was effective in finding Candida; salivary flow rate, use of prosthesis, and presence of oral lesions and symptoms were similar in oral Candida carriers and negative patients. Most smokers were Candida carriers.

Candida; Diabetes mellitus; type 2; Mexico; Mouth

FUNDAMENTOS:

A prevalência de candidíase oral em pacientes diabéticos é de 13,7- 64%. A espécie mais frequentemente isolada é Candida albicans(75-86,5%). OBJETIVO: Obter a prevalência de portadores de Candida em pacientes com diabetes mellitus tipo 2 para identificar as espécies da levedura. Desenho do estudo: Aberto, observacional, descritivo, transversal e prospectivo.

MÉTODOS:

Incluímos pacientes voluntários dentro da Maratona Nacional do Diabetes e realizamos medida da glicose sanguínea, teste sialométrico, coloração de Gram da citologia esfoliativa, cultura em ágar Sabouraud dextrose e CHROMagar Candida TM. Os resultados foram analisados com estatística descritiva.

RESULTADOS:

Foram examinados 141 pacientes (média de idade de 57 anos), 103 mulheres (73%) e 38 homens (26,9%). A citologia esfoliativa foi positiva em 32 casos (23 com lesão oral), 78 tinham lesão oral, mas não tinham Candida (93,9%). Candida foi isolado em 58 pacientes (41,1%), 21(45,6%) tiveram glicemia superior a 126 mg / dl e 37 (38,9%) tiveram glicemia inferior a 126 mg / dl. A espécie mais frequente foi C. albicans (82,7%). 42 portadores de Candida tinham fluxo salivar maior que 20 mm(72,4%) e 16(27,5%) tinham hiposalivação. Candida foi isolado em 25 de 79 pacientes com prótese dentária (31,6%), 9 de 15 fumantes (60%), e 22 de 71 com sintomas (30,9%).

CONCLUSÕES:

A prevalência de portadores de Candida oral em pacientes com diabetes mellitus tipo 2 no México foi semelhante a outros países; citologia esfoliativa foi efetiva em encontrar Candida; fluxo salivar, uso de prótese, presença de lesão oral e sintomatologia foi semelhante em portadores de Candida oral e pacientes não portadores. A maioria dos fumantes eram portadores de Candida.

Boca; Candida; Diabetes mellitus tipo 2; México

INTRODUCTION

Patients with type 2 diabetes mellitus (DM) are at an increased risk of having opportunistic infections, including oral and vaginal candidiasis, periodontal and gingival diseases, dental caries, and salivary dysfunction.¹

Prevalence of nonspecific symptoms such as gustatory changes, glossodynia, and halitosis is 1856%.² Other symptoms reported are dysgeusia, oral paresthesia, hotness or burning sensation.^{3 , 4}

Oral candidiasis is a superficial fungal opportunistic infection, caused mainly by Candida albicans. ⁵ One factor that favors colonization of the mouth is poor glucose control, but this is still controversial. ^{6 , 7}

Prevalence of oral candidiasis in diabetic patients is 13.7 to 64%, and lesions are asymptomatic in most cases.^{6 , 8}

The Candida species most frequently isolated from the oral cavity in patients with DM are Candida albicans (75 to 86.5%), C. krusei (4%), and C. glabrata (5%). They are mainly found on the surface of the tongue, followed by the palate and oral mucosa.^{9 , 10}

Identification of Candida species is based on characteristics such as macro and microscopic morphology, carbohydrate assimilation, and use of chromogenic media such as Aniline Blue, Fluoroplate (tm), Candichrom (tm), CandiSelect (tm), and CHROMagar Candida (tm). The latter enables the identification of C. albicans, C. tropicalis, C. glabrata, and C. krusei (green, blue, bright pink, and pale pink colonies, respectively), and although it is one of the most used media, there have been variations in sensitivity and specificity.^{11 - 20}

MATERIALS AND METHODS

Our goal was to determine the prevalence of oral Candida carriers among patients with type 2 DM using Gram-stained exfoliative cytology and primoisolation culture on Sabouraud dextrose agar to identify the isolated species with CHROMagar Candida (tm) and to determine blood glucose, rate of salivary secretion, use of dental prosthesis, smoking and oral lesions, and symptoms such as dryness, burning sensation, and bad taste.

This is a descriptive, open, observational, prospective, and cross-sectional study.

We included patients older than 18 years of both sexes with confirmed diagnosis of type II DM seen at the Mycology Section of the Department of Dermatology at Hospital General Dr. Manuel Gea Gonzalez during the XV National Diabetes Marathon in Mexico City.

Results were analyzed using descriptive statistics.

This study was approved by the Hospital Ethics Committee, and the subjects signed the informed consent form.

A sialometry test was performed as described by Lopez et al., and lesions suggestive of oral candidiasis were reported. To explore the oral cavity, a calibration trial was performed intra and inter-examiners based on the criteria by Ramirez et al.^{4 , 20}

Patients were sampled with a sterile swab for Gram-stained exfoliative cytology to demonstrate the presence of yeast and filamentous structures. Culture on Sabouraud dextrose agar (Becton Dickinson & BBL (tm)) was also done and maintained at 37°C for up to two weeks. We conducted a direct examination of the cultures with sterile saline solution to verify the presence of yeast.

CHROMagar Candida (Becton Dickinson & BBL(tm)) plates were inoculated and maintained at 37°C for up to 48 hours. Then, we identified the different species of Candida.

RESULTS

We examined 141 patients with type 2 diabetes mellitus: 103 women (73%) and 38 men (26.9%). Their age varied from 26 to 87 years (mean age 57).

Of the total patients enrolled in the study, 46 (32.6%) had blood glucose greater than 126 mg/dl, of whom 21 (45.6%) were Candida carriers. Of the 95 remaining patients with blood glucose less than 126 mg/dl, 37 (38.9%) had Candida. Exfoliative cytology showed yeast and filaments in 32 cases (55.1%), and 9 cases were negative. Of the group of 83 patients in whom Candida sp was not isolated, 78 (93.9%) had oral lesions.

Candida spp was isolated in 58 patients (41.1 %) using culture on Sabouraud dextrose agar: 45 women (75.5%) and 18 men (31%). The most frequently isolated species was C. albicans (82.7%). The species was not identified in two cases (Table 1).

TABLE 1

Isolated species of Candida sp.

Species	No	%
Candida albicans	48	82.7
Candida glabrata	5	8.6
Candida kruzei	3	5.1
Candida sp	2	3.4

Forty-two patients (72.4%) with Candida had a salivary flow rate higher than 20 mm, and 16 (27.5%) had hyposalivation (saliva flow lower than 20 mm). Among the negative Candida patients, 69 (83%) had normal salivary flow rate, and 14 (16%) had hyposalivation.

Of the 79 patients in the study who used dental prosthesis, 25 (31.6%) were Candida carriers, and 64 (81%) were negative.

Of all patients, 15 were smokers, and 9 (60%) of them were Candida carriers.

Twenty-two (37.9%) Candida carriers had symptoms, as well as 49 (59%) patients from the negative group (Table 2).

TABLE 2

Frequency of risk factors in Candida sp carriers

Factor	No	%
Prothesis	25	43.1
Smoking	9	15.5
Oral lesions	23	39.6
Symptoms	22	37.9

DISCUSSION

In our study, prevalence of Candida carriers was 55.1%, which is similar to that found in other reports. The same is true for prevalence of Candida albicans. ^{1 , 5 - 10} Of the total number of Candida carriers, 75.5% were women, due to the greater number of women participating in the marathon and included in the study.

Twenty-three patients with oral lesions had positive Gram-stained exfoliative cytology, while 9 patients did not. Candida was not identified by exfoliative cytology or by culture in 83 patients with oral lesions. From these data, we deduced that not all oral lesions were caused by Candida. Therefore, it is necessary to confirm the presence of Candida with a proper procedure to avoid an unjustified antimycotic treatment. Exfoliative cytology was an effective, simple, fast, and economical tool to diagnose oral candidiasis.^{1 , 5}, and ^{6 , 8 , 10}

Among patients with Candida sp, 42 (72.4%) had a normal salivary flow rate, and just 16 (27.5%) had hyposalivation. Among the negative cases, 69 (83%) had normal salivary flow rate, and 14 (16%) had hyposalivation. Thus, we can conclude that a lower salivary flow rate did not change the probability of being a carrier.⁴

Among 79 dental prosthesis users, 25 (31.6%) had the yeast, and 64 (81%) were negative. This finding does not correspond to the usual belief that the use of dental prosthesis is a predisposing risk factor for developing oral candidiasis.^{1 , 8}

Fifteen patients enrolled in the study were smokers, of whom 9 (60%) were Candida carriers. Therefore, it can be inferred that smoking was a relative risk factor for presence of Candida in the oral cavity.

Of seventy-one patients who had symptoms, 22 (37.9%) were Candida carriers, while (59%) were not (Table 2), which suggests that the presence of symptoms was not related to the possibility of carrying Candida in the oral cavity, but perhaps to drugs used to control diabetes.^{2 , 3 , 4}

CONCLUSIONS

In our study, prevalence of Candida carriers was 55.1%, which is similar to that found in other reports. The same is true for prevalence of Candida albicans. ^{1 , 5 - 10} Not all oral lesions were caused by Candida. Therefore, it is necessary to confirm the presence of Candida with a proper procedure to avoid an unjustified antimycotic treatment. A lower salivary flow rate did not change the probability of being a carrier.⁴ In our study, the use of dental prosthesis did not show to be a predisposing risk factor for developing oral candidiasis.^{1 , 8} Smoking was a relative risk factor for the presence of Candida in the oral cavity. Presence of symptoms was not related to the possibility of carrying Candida in the oral cavity, but perhaps to drugs used to control diabetes.^{2 , 3 , 4}

REFERENCES

• ¹
  Ship JA. Diabetes and oral health: an overview.J AmDent Assoc. 2003; 134 supl: 4-10.
• ²
  Nevazesh M, Garay J, Vernon J. Relationship between salivary flow rates and Candida albicans counts. Oral Surg Oral Med Oral Pathol Oral RadiolEndod. 1995;80: 284-8.
• ³
  Shlossman, Knowler, Pettitt DJ, Genco RJ. Type 2 diabetes mellitus and periodontal disease. J Am Dent Assoc.1990;121:532-6.
• ⁴
  López-Jornet P, Saura-Inglés A, Martínez-Mondéjar B, Bermejo-Fenoll A. Valoración de latasa de flujo salival en pacientes con diabetes tipo 1 y tipo 2. Archivos de Odontoestomatol. 1996;12:690-7.
• ⁵
  GuggenheimerJ, Moore PA, Rossie K, Myers D, Mongelluzzo MB, Block HM, et al. Insulindependent Diabetes Mellitus and oral tissuepathologies II. Prevalence and characteristics of Candida and candidal lesions.Oral Surg Oral Med Oral Radiol Endod.2000;89:570-6.
• ⁶
  Molina SD, Monroy E, Arenas R, Fernández RF, Rubalcaba PJ, Fabián SMG. Frecuencia de candidiasis oral en pacientes diabéticos tipo 2ambulatoriosenel Hospital General "Dr. Manuel Gea González". Estudio Clínico Micológico. Dermatología Rev Mex.2002;46:3-9.
• ⁷
  De la Rosa E, Aranda S, Cruz S, Mondragón A. Frecuencia de manifestacionesbucalesen pacientes diabéticos tipo 2 de una unidad de medicina familiar del IMSS. Rev Cienc Clín.2006;2:81-8.
• ⁸
  Belazi M, Velegraki A, Fleva A, Gidarakou I, Papanaum L, Baka D, et al. Candidalovergrowth in diabeticpatients: potentialpredisposingfactors. Mycoses 2005;48:192-6.
• ⁹
  Lynch DP. Oral candidiasis.History, classification, and clinical presentation.Oral Med Oral Pathol Oral. 1994;78:189-93.
• ¹⁰
  Goldschmidt MC, Fung DY, Grant R, White J, Brown T. New aniline blue dye medium for rapid identification and isolation of Candida albicans. J Clin Microbiol 1991;29:1095-9.
• ¹¹
  Hoppe JE, Frey P. Evaluation of six commercial tests and the germ-tube test for presumptive identification of Candida albicans. Eur J Clin Microbiol Infect Dis 1999;18:188- 91.
• ¹²
  Bauters TG, Moerman M, Vermeersch H, Nelis HJ. Colonization of voice prostheses by albicans and non-albicans Candida species. Laryngoscope. 2002;112:708-12.
• ¹³
  Waller J, Koenig H, Debruyne M, Contant G. Evaluation d'un nouveau milieu isolement des levures et de diagnostiquerapide de Candida albicans. Rev Fr Lab. 1993;252:89-92.
• ¹⁴
  Freydier AM, Buchaille L, Gille Y. Comparison of three commercial media for direct identification and discrimination of Candida species in clinical specimens. Eur J Clin Microbiol Infect Dis. 1997;16:464-7.
• ¹⁵
  Cooke VM, Miles RJ, Price RG, Midgley G, Khamri W, Richardson AC. New chromogenic agar medium for the identification of Candida spp. Appl Environ Microbiol.2002;68:3622-7.
• ¹⁶
  Bernal S, Martin Mazuelos E, Garcia M, Aller AI, Martinez MA, Gutierrez MJ. Evaluation of CHROMagar candida medium for the isolation and presumptive identification of species of Candida of clinical importance. Diagn Microbiol Infect Dis. 1996;24:201-4.
• ¹⁷
  Odds FC, Bernaerts R. CHROMagar candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol. 1994;32:1923-9.
• ¹⁸
  Scarparo C, Piccoli P, Ricordi P, Scagnelli M. Comparative evaluation of two commercial chromogenic media for detection and presumptive identification of urinary tract pathogens. Eur J Clin Microbiol Infect Dis. 2002;21:283-9.
• ¹⁹
  Momani OM. Cost-effectiveness and efficacy of CHROMagar candida medium in clinical specimens. East Mediterr Health J. 2000;6:968-78.
• ²⁰
  Ramírez AV, Mosqueda TA, Hernández LLH. Estudio epidemiológico de las lesiones de la mucosa oral. México. Cuadernos de C.B.S. No.11. U.A.M.X. 1986. 75 p.

• *
  Work conducted at Hospital General Dr. Manuel Gea González, National Institute of Respiratory Diseases (Instituto Nacional de Enfermedades Respitarorias) - Mexico City, Federal District, Mexico.

Publication Dates

• Publication in this collection
  Apr 2013

History

• Received
  31 May 2012
• Accepted
  23 July 2012